Provision of Blood Products

P-First offers a comprehensive range of blood products tailored to meet the specific needs of various patients, including those in emergency situations, patients with frequent transfusion reactions, neonates, and patients requiring CMV-safe or irradiated blood products. The available products include:

Whole Blood.
Whole Blood is the simplest and most direct form of blood product, collected directly from donors without being separated into its components. It contains red blood cells, white blood cells, platelets, plasma, and clotting factors. Whole blood transfusion is primarily used in situations requiring volume replacement in patients, such as those experiencing significant blood loss due to trauma or surgery
Red Cell Concentrate (RCC).
Red Cell Concentrate, commonly referred to as packed red blood cells (PRBCs), is produced by centrifuging whole blood to remove a portion of the plasma. This process concentrates the red blood cells, which are essential for transporting oxygen throughout the body. RCC transfusions are indicated for patients suffering from anemia, significant blood loss, or those undergoing surgery who need to increase their red blood cell mass without excess plasma, reducing the risk of volume overload.
Random Donor Platelets.
Random Donor Platelets are collected from whole blood donations. Each unit comes from a single donor, and multiple units are often pooled to achieve a therapeutic dose. These platelet transfusions are used to prevent or treat bleeding in patients with platelet deficiencies or dysfunction, such as those undergoing chemotherapy, with bone marrow disorders, or experiencing acute blood loss.
Mega Dose Platelets.
Mega Dose Platelets, or single donor platelets, are collected through apheresis from a single donor, providing a higher platelet count per unit. This method is efficient and reduces the patients exposure to multiple donors, lowering the risk of transfusion-transmitted infections and alloimmunization. Mega dose platelets are especially useful in patients with thrombocytopenia (low platelet count) who are not responsive to random donor platelets or those who require frequent platelet transfusions.
Fresh Frozen Plasma (FFP).
Fresh Frozen Plasma is the liquid portion of blood, frozen soon after collection to preserve clotting factors. FFP is used to treat conditions involving coagulation factor deficiencies, such as liver disease, disseminated intravascular coagulation (DIC), or massive transfusion protocols. It provides all coagulation factors except platelets, making it crucial for patients needing an immediate correction of clotting factor deficiencies.
Cryoprecipitate is derived from thawing FFP at low temperatures, which precipitates a protein-rich fraction containing high levels of fibrinogen, factor VIII, factor XIII, von Willebrand factor, and fibronectin. It is specifically used in conditions such as Hemophilia A, von Willebrands Disease, and hypofibrinogenemia, where specific clotting factor deficiencies can be targeted with this concentrated product.
Cryo Poor Plasma.
Cryo Poor Plasma is the supernatant plasma remaining after the cryoprecipitate has been removed. It still contains most clotting factors but in lower concentrations than FFP. Its primary use is for patients who require plasma transfusion but for whom the high levels of fibrinogen in FFP or cryoprecipitate could be problematic, such as those at risk for thrombosis or those with a need for volume expansion without excessive coagulation factor supplementation.
App screenshot

Plasma Exchange Services

P-First addresses critical needs with plasma exchange services, aiming for outpatient accessibility. This service is crucial for conditions where plasma removal and replacement are indicated. Future endeavors include dedicated donor recruitment for apheresis platelets, ensuring rapid availability. This proactive approach highlights P-First's commitment to innovative, economically feasible healthcare solutions.

App screenshot

Emergency Blood Transfusion Support

To address the challenges of logistics and availability of blood products in emergency situations, P-First is developing a Massive Transfusion Protocol (MTP) for obstetrical hemorrhage and other critical scenarios. This initiative includes the production of lyophilized plasma products for room temperature storage, ensuring the availability of life-saving products when and where they are needed most.

Bedside Blood Transfusion

P-First's technology solutions, including P-BECS (P-First Blood Establishment Computer Software), are designed to streamline and manage blood bank processes, facilitating safe and efficient bedside blood transfusions. This system supports donor and patient registration, real-time temperature monitoring, and seamless integration with clinical service processes.

Job openings

  • Role
    Streamlining Blood Bank Processes with P-BECS
    P-First introduces the P-First Blood Establishment Computer Software (P-BECS), a sophisticated technology designed to modernize and streamline blood bank operations. This innovative software facilitates the efficient management of blood bank processes, from donor registration through to the final step of bedside blood transfusion. P-BECS aims to ensure that the entire journey of blood products is tracked and managed with precision, enhancing safety and efficiency.
  • Role
    Enhancing Bedside Blood Transfusion Safety
    Safety at the bedside during blood transfusions is paramount. P-BECS plays a critical role in this aspect by supporting real-time temperature monitoring of blood products, ensuring they are stored and transported within safe temperature ranges. Additionally, the system incorporates mechanisms for thorough donor and patient registration, contributing to a robust traceability framework that minimizes the risk of errors and enhances transfusion safety.
  • Role
    Integrating Clinical Service Processes
    P-BECS is designed not only as a standalone system but as one that seamlessly integrates with existing clinical service processes. This integration facilitates a unified approach to patient care, where clinical data and blood transfusion requirements are harmonized within a single platform. By connecting the dots between various departments and services, P-BECS ensures that patient care is coordinated, efficient, and responsive to the immediate needs of bedside blood transfusion scenarios.

Diagnostic Services

P-First, in partnership with Nuzhat Lab Diagnostics, provides a full spectrum of diagnostic services. This collaboration focuses on addressing the complexities of blood transfusion and hematology, offering routine and molecular testing to support patient blood management.

Partnership embodies the principle that patient benefit is paramount, ensuring access to essential diagnostic services.

Consultation and Patient Blood Management

Understanding the gaps in knowledge and accessibility, P-First offers consultancy and training services aimed at elevating the standards of blood banks and transfusion facilities. This includes guidance on the preparation of blood components, enhancing storage capabilities, and ensuring compliance with legislative requirements. P-First's approach is comprehensive, covering document organization, SOP upgrades, and staff training to improve overall blood safety and quality.

A significant focus of P-First's consultancy services is on the meticulous preparation of blood components. By providing comprehensive training and advice on best practices for processing, handling, and storing blood products, P-First ensures that all components meet the highest safety standards. This not only improves patient outcomes but also optimizes the use of valuable blood resources.

Monitoring and Hemovigilance

Through its dedicated software, P-BECS, P-First implements stringent monitoring and hemovigilance protocols, covering donor screening, real-time report generation, and complete component traceability. This comprehensive approach ensures the safety and quality of the blood supply, from donor to recipient.

This initiative is part of P-First's broader commitment to enhancing blood safety and accessibility in Pakistan, addressing the urgent need for high-quality transfusion services. The detailed approach includes:

  • Comprehensive Donor Screening and Component Traceability:P-BECS is designed to facilitate thorough donor screening processes, ensuring that all donated blood is rigorously tested for transfusion-transmitted infections (TTIs) before being processed and stored. Additionally, the software enables complete traceability of blood components from the point of donation through to transfusion, allowing for precise tracking and management of blood products. This level of traceability is crucial for quickly addressing any issues that may arise, ensuring the safety and reliability of the blood supply.
  • Real-Time Report Generation for Enhanced Hemovigilance: The software supports real-time report generation, providing immediate access to critical data on blood inventories, donor records, and transfusion outcomes. This feature is instrumental in identifying trends, managing risks, and implementing corrective actions promptly. By enabling real-time data analysis, P-BECS plays a pivotal role in P-First's hemovigilance system, ensuring continuous improvement in blood safety and patient care.
  • Centralization of Blood Safety Solutions: By integrating these advanced functionalities into a single software platform, P-First centralizes blood safety solutions, streamlining operations and enhancing efficiency. This centralization not only makes blood safety solutions more accessible and affordable but also significantly contributes to the health sector in Pakistan by ensuring that patients receive safe, high-quality blood transfusions. P-First's mission to prevent the spread of TTIs and improve patient care is thus supported by a solid foundation of technological innovation and operational excellence.

P-BECS Software: A Single Solution for Streamlined Blood Safety and Enhanced Patient Care

The P-First Blood Establishment Computer Software (P-BECS) is a cutting-edge solution designed to streamline blood bank operations and enhance blood safety. With its intuitive interface, users can easily access reports, manage blood inventories, and track donor screenings in real-time. P-BECS serves as a pivotal tool for ensuring traceability and maintaining high standards of patient care in the transfusion process, marking a significant advancement in hemovigilance efforts.